Songül Keskin Kavak
Research Subjects
Songül Keskin Kavak has a total of 246 co-authors. Here are the top co-authors by number of shared publications:
- Lale Aktekin
SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, ANKARA DR. ABDURRAHMAN YURTASLAN ONKOLOJİ SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ
6 shared publications Engin Eren Kavak
Ankara University Medical Faculty, Department of Medical Oncology, Turkey
3 shared publications- Engin Eren Kavak
Ankara Etlik City hospital
3 shared publications - Burcu Sevingül2 shared publications
Lale Aktekin
SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, ANKARA DR. ABDURRAHMAN YURTASLAN ONKOLOJİ SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ
2 shared publications- Sibel Mandıroğlu
University of Health Sciences
2 shared publications
Latest Publications
- 1 September 2025
- Published by Sciencedomain International in Journal of Advances in Medicine and Medical Research
- Vol. 37 (9) , 97-105
Effects of Nonthyroidal Illness Syndrome on Functional Outcomes in Patients with Stroke
Objectives: The purpose of the study was to investigate the effect of nontiroidal illness syndrome (NTIS) on functional outcomes in patients with stroke. Materials and Methods: The study included 204 (116 women, 88 men) patients with stroke due to cerebrovascular events. Acute and subacute stroke patients were included. Patients who had thyroid disease, severe liver disease and those diseases that lead to metabolic abnormalities were excluded. Demographic and clinical datas were recorded. Serum fT3, fT4 and TSH levels were investigated at admission. Functional Independence Measure (FIM) was used for functional assessment at admission and at discharge. Results: It was identified that in 60 of 204 patients (29.4%) had NTIS. Patients with NTIS (group 1) and without NTIS (group 2) had similar demographic characteristics (p>0.05). Admission (p=0.006) and discharge (p=0.005) FIM values of group 1 patients were statistically lower than group 2 patients. There was no significant difference between the groups in terms of FIM gain (FIM discharge-FIM admission) scores (p=0.425). In contrast, length of hospital stay of the patients in group 1 (45.20± 8.97 days) was found to be significantly longer (p=0.01) than group 2 (34.02±10.56 days). NTIS prevalence was 21.7% among acute stroke patients and 66.7% among subacute stroke patients. In multiple regression analysis, lower fT3 levels were independently associated with longer rehabilitation length of stay. Conclusion: Functional status of patients with NTIS was worse than patients with non-NTIS both at hospital admission and at discharge. Benefits derived from the rehabilitation program was similar in both groups, however NTIS prolong the duration of rehabilitation in patients with stroke.
- 1 September 2025
- Published by Sciencedomain International in Journal of Advances in Medicine and Medical Research
- Vol. 37 (9) , 97-105
Effects of Nonthyroidal Illness Syndrome on Functional Outcomes in Patients with Stroke
Objectives: The purpose of the study was to investigate the effect of nontiroidal illness syndrome (NTIS) on functional outcomes in patients with stroke. Materials and Methods: The study included 204 (116 women, 88 men) patients with stroke due to cerebrovascular events. Acute and subacute stroke patients were included. Patients who had thyroid disease, severe liver disease and those diseases that lead to metabolic abnormalities were excluded. Demographic and clinical datas were recorded. Serum fT3, fT4 and TSH levels were investigated at admission. Functional Independence Measure (FIM) was used for functional assessment at admission and at discharge. Results: It was identified that in 60 of 204 patients (29.4%) had NTIS. Patients with NTIS (group 1) and without NTIS (group 2) had similar demographic characteristics (p>0.05). Admission (p=0.006) and discharge (p=0.005) FIM values of group 1 patients were statistically lower than group 2 patients. There was no significant difference between the groups in terms of FIM gain (FIM discharge-FIM admission) scores (p=0.425). In contrast, length of hospital stay of the patients in group 1 (45.20± 8.97 days) was found to be significantly longer (p=0.01) than group 2 (34.02±10.56 days). NTIS prevalence was 21.7% among acute stroke patients and 66.7% among subacute stroke patients. In multiple regression analysis, lower fT3 levels were independently associated with longer rehabilitation length of stay. Conclusion: Functional status of patients with NTIS was worse than patients with non-NTIS both at hospital admission and at discharge. Benefits derived from the rehabilitation program was similar in both groups, however NTIS prolong the duration of rehabilitation in patients with stroke.
- Open Access
- 25 March 2025
- Published by MediHealth Academy in Ankyra Medical Journal
- Vol. 4 (2) , 22-26
Cancer patients' rehabilitation needs and their fulfillment status
Aims: Advances in cancer treatment have improved patients' survival rates; however, longer survival brings physical and psychosocial challenges. Cancer rehabilitation aims to mitigate these issues, preserving functionality and quality of life. This study aimed to evaluate the rehabilitation needs of oncology inpatients and the extent to which these needs are met, thereby raising awareness. Methods: This cross-sectional, single-center study included 200 inpatients from the medical oncology service who voluntarily participated. A literature-based questionnaire was administered to assess patients' demographic and clinical characteristics, physical activity levels, and symptoms that may require rehabilitation. Performance status was determined using the Eastern Cooperative Oncology Group (ECOG) scale. Electronic patient records were reviewed to identify those who received a physical therapy and rehabilitation (PTR) consultation. The characteristics of patients who received and did not receive PTR consultation were statistically compared (p<0.05 significance level). Results: The median age of the study participants was 61 years, with 59% being male. The most common symptoms requiring rehabilitation were fatigue (86%), pain (35%), and ambulation difficulty (32.5%). ECOG performance score was 2 and above in 41.5% of the patients. Only 27 patients (13.5%) received PTR consultation. Patients who received PTR consultation had significantly higher ECOG scores (p<0.001), higher rates of metastatic disease (p=0.047), and lower rates of independent feeding (p<0.001). Conclusion: Although symptoms such as fatigue, pain, and mobility issues that require rehabilitation are common among oncology patients, referral rates to PTR clinics and access to rehabilitation services remain low. Identifying and addressing these needs is crucial for improving patient outcomes. Therefore, increasing awareness and strengthening collaboration between oncology and rehabilitation clinics is essential.
- 25 March 2025
- Published by MediHealth Academy in Ankyra Medical Journal
- Vol. 4 (2) , 22-26
Open AccessCancer patients' rehabilitation needs and their fulfillment status
Aims: Advances in cancer treatment have improved patients' survival rates; however, longer survival brings physical and psychosocial challenges. Cancer rehabilitation aims to mitigate these issues, preserving functionality and quality of life. This study aimed to evaluate the rehabilitation needs of oncology inpatients and the extent to which these needs are met, thereby raising awareness. Methods: This cross-sectional, single-center study included 200 inpatients from the medical oncology service who voluntarily participated. A literature-based questionnaire was administered to assess patients' demographic and clinical characteristics, physical activity levels, and symptoms that may require rehabilitation. Performance status was determined using the Eastern Cooperative Oncology Group (ECOG) scale. Electronic patient records were reviewed to identify those who received a physical therapy and rehabilitation (PTR) consultation. The characteristics of patients who received and did not receive PTR consultation were statistically compared (p<0.05 significance level). Results: The median age of the study participants was 61 years, with 59% being male. The most common symptoms requiring rehabilitation were fatigue (86%), pain (35%), and ambulation difficulty (32.5%). ECOG performance score was 2 and above in 41.5% of the patients. Only 27 patients (13.5%) received PTR consultation. Patients who received PTR consultation had significantly higher ECOG scores (p<0.001), higher rates of metastatic disease (p=0.047), and lower rates of independent feeding (p<0.001). Conclusion: Although symptoms such as fatigue, pain, and mobility issues that require rehabilitation are common among oncology patients, referral rates to PTR clinics and access to rehabilitation services remain low. Identifying and addressing these needs is crucial for improving patient outcomes. Therefore, increasing awareness and strengthening collaboration between oncology and rehabilitation clinics is essential.
- Open Access
- 18 January 2025
- Published by MediHealth Academy in Journal of Orthopedics Research and Rehabilitation
- Vol. 3 (1) , 20-26
Sarcopenia
Sarcopenia is the progressive and involuntary loss of muscle mass and strength that occurs with elderly age. The definition of sarcopenia was first made by Rosenberg et al. in 1989. In 2010, the European Working Group on Sarcopenia in Older People (EWGSOP1) characterised the condition primarily by low muscle mass. The definition of sarcopenia that has been most widely adopted is that proposed by the EWGSOP1, which was updated in 2019 to become the EWGSOP2. Acute and chronic sarcopenia was included in the EWGSOP2 guideline for the first time. Although there is no consensus on the exact aetiology of sarcopenia, it is widely accepted that the condition is related to the natural ageing process. There are many chronic diseases associated with sarcopenia, including: cancer, chronic obstructive pulmonary disease (COPD), chronic heart failure, parkinson, cognitive impairment, depression, chronic kidney disease, diabetes mellitus (DM), human immunodeficiency virus (HIV), anorexia and osteoporosis. The assessment of sarcopenia includes a variety of methods and screening tools that are easily accessible and practical. The EWGSOP2 algorithm is delineated as "find–assess–confirm–severity," or F-A-C-S. A multidisciplinary approach is imperative for the early diagnosis and treatment of this condition. Given the multifactorial pathogenesis of sarcopenia, no definitive pharmacological therapy currently exists. Enhanced patient education and adherence to clinical recommendations are pivotal. The most effective strategies for combating sarcopenia involve a combination of nutritional support and resistance–aerobic exercise programs. Further research is needed to explore new pharmacological treatment approaches.
- 18 January 2025
- Published by MediHealth Academy in Journal of Orthopedics Research and Rehabilitation
- Vol. 3 (1) , 20-26
Open AccessSarcopenia
Sarcopenia is the progressive and involuntary loss of muscle mass and strength that occurs with elderly age. The definition of sarcopenia was first made by Rosenberg et al. in 1989. In 2010, the European Working Group on Sarcopenia in Older People (EWGSOP1) characterised the condition primarily by low muscle mass. The definition of sarcopenia that has been most widely adopted is that proposed by the EWGSOP1, which was updated in 2019 to become the EWGSOP2. Acute and chronic sarcopenia was included in the EWGSOP2 guideline for the first time. Although there is no consensus on the exact aetiology of sarcopenia, it is widely accepted that the condition is related to the natural ageing process. There are many chronic diseases associated with sarcopenia, including: cancer, chronic obstructive pulmonary disease (COPD), chronic heart failure, parkinson, cognitive impairment, depression, chronic kidney disease, diabetes mellitus (DM), human immunodeficiency virus (HIV), anorexia and osteoporosis. The assessment of sarcopenia includes a variety of methods and screening tools that are easily accessible and practical. The EWGSOP2 algorithm is delineated as "find–assess–confirm–severity," or F-A-C-S. A multidisciplinary approach is imperative for the early diagnosis and treatment of this condition. Given the multifactorial pathogenesis of sarcopenia, no definitive pharmacological therapy currently exists. Enhanced patient education and adherence to clinical recommendations are pivotal. The most effective strategies for combating sarcopenia involve a combination of nutritional support and resistance–aerobic exercise programs. Further research is needed to explore new pharmacological treatment approaches.
- Open Access
- 18 January 2025
- Published by MediHealth Academy in Journal of Orthopedics Research and Rehabilitation
- Vol. 3 (1) , 9-13
Evaluation of Covid-19-related musculoskeletal pain in healthcare workers during the pandemic
Aims: To investigate the prevalence, characteristics, and musculoskeletal distribution of pain, one of the most frequently encountered complications among healthcare professionals during the COVID-19 pandemic. Methods: The study included healthcare workers who had recovered from COVID-19 at least six months before their inclusion. Demographic data of the participants were collected. Pain levels were assessed with the Visual Analog Scale. The "Oswestry Low Back Pain Disability Questionnaire" was used to measure low back pain and disability levels, which aims to assess how pain affects activities of daily living. The "Douleur Neuropathique 4 Questionnaire" interview section was used to assess the level of neuropathic pain. Results: A total of 101 participants with a mean age of 37.72 ± 1.22 years were included in the study. Of these participants, 78 (77.2%) were female and 23 (22.8%) were male. Of the participants, 32 (31.7%) were physicians, 34 (33.7%) were nurses, and 35 (34.7%) were healthcare workers. The most common areas of pain reported in healthcare workers in our study were the head, lower back, and back. A statistically significant difference was observed in the analysis of Oswestry Scores between different occupational groups (p <0.001). Subgroup analyses showed that there was no statistically significant difference between nurses and other healthcare personnel (p = 0.082). However, a significant difference was observed between doctors and nurses (p <0.001) and also between doctors and other healthcare personnel (p = 0.008). The most frequently reported neuropathic symptoms were numbness, pinprick sensations, and tingling. Conclusion: Our study that examines the location and character of pain in the musculoskeletal system in healthcare workers can support fundamental strategies in the protection of healthcare workers and the continuity of healthcare system delivery. Developing necessary prevention strategies is crucial to prepare healthcare workers for managing future outbreaks.
- 18 January 2025
- Published by MediHealth Academy in Journal of Orthopedics Research and Rehabilitation
- Vol. 3 (1) , 9-13
Open AccessEvaluation of Covid-19-related musculoskeletal pain in healthcare workers during the pandemic
Aims: To investigate the prevalence, characteristics, and musculoskeletal distribution of pain, one of the most frequently encountered complications among healthcare professionals during the COVID-19 pandemic. Methods: The study included healthcare workers who had recovered from COVID-19 at least six months before their inclusion. Demographic data of the participants were collected. Pain levels were assessed with the Visual Analog Scale. The "Oswestry Low Back Pain Disability Questionnaire" was used to measure low back pain and disability levels, which aims to assess how pain affects activities of daily living. The "Douleur Neuropathique 4 Questionnaire" interview section was used to assess the level of neuropathic pain. Results: A total of 101 participants with a mean age of 37.72 ± 1.22 years were included in the study. Of these participants, 78 (77.2%) were female and 23 (22.8%) were male. Of the participants, 32 (31.7%) were physicians, 34 (33.7%) were nurses, and 35 (34.7%) were healthcare workers. The most common areas of pain reported in healthcare workers in our study were the head, lower back, and back. A statistically significant difference was observed in the analysis of Oswestry Scores between different occupational groups (p <0.001). Subgroup analyses showed that there was no statistically significant difference between nurses and other healthcare personnel (p = 0.082). However, a significant difference was observed between doctors and nurses (p <0.001) and also between doctors and other healthcare personnel (p = 0.008). The most frequently reported neuropathic symptoms were numbness, pinprick sensations, and tingling. Conclusion: Our study that examines the location and character of pain in the musculoskeletal system in healthcare workers can support fundamental strategies in the protection of healthcare workers and the continuity of healthcare system delivery. Developing necessary prevention strategies is crucial to prepare healthcare workers for managing future outbreaks.
- Open Access
- 9 January 2025
- Published by Al-Kindi Center for Research and Development in Journal of Medical and Health Studies
- Vol. 6 (1) , 77-82
Systemic Immune-inflammation Index: A Potential Indicator of Disease Activity in Sjögren's Syndrome?
Given the autoimmune and inflammatory nature of Sjögren's Syndrome(SS), it is essential to identify reliable indicators to monitor disease progression and inform treatment strategies. This study aims to evaluate the potential of the Systemic Immune-Inflammation Index (SII) as a biomarker for assessing disease activity in SS. A prospective analysis was conducted on two groups: the first comprising 52 patients diagnosed with SS and the second a healthy control group. SII values were calculated using the following formula: platelet count multiplied by the neutrophil-to-lymphocyte ratio. The degree of disease activity was gauged according to the EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI) criteria. This study examines the correlations between SII and several clinical and patient-reported outcome measures, including various inflammatory markers. Compared to the control group, the SS patient cohort displayed slightly elevated SII levels (p = 0.04). The SII exhibited a correlation with elevated levels of C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), suggesting its potential as a marker of systemic inflammation. Nevertheless, the observed correlation between SII and ESSDAI scores (r = 0.0903) was weak and not statistically significant (p = 0.524). Although SII values were higher in SS patients and correlated with systemic inflammation markers, no statistically significant relationship was observed between these values and disease activity, as measured by ESSDAI.Thus, while SII may reflect systemic inflammation, its utility as a marker for disease activity in SS remains limited. Further studies are needed to elucidate its role in clinical settings.
- 9 January 2025
- Published by Al-Kindi Center for Research and Development in Journal of Medical and Health Studies
- Vol. 6 (1) , 77-82
Open AccessSystemic Immune-inflammation Index: A Potential Indicator of Disease Activity in Sjögren's Syndrome?
Given the autoimmune and inflammatory nature of Sjögren's Syndrome(SS), it is essential to identify reliable indicators to monitor disease progression and inform treatment strategies. This study aims to evaluate the potential of the Systemic Immune-Inflammation Index (SII) as a biomarker for assessing disease activity in SS. A prospective analysis was conducted on two groups: the first comprising 52 patients diagnosed with SS and the second a healthy control group. SII values were calculated using the following formula: platelet count multiplied by the neutrophil-to-lymphocyte ratio. The degree of disease activity was gauged according to the EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI) criteria. This study examines the correlations between SII and several clinical and patient-reported outcome measures, including various inflammatory markers. Compared to the control group, the SS patient cohort displayed slightly elevated SII levels (p = 0.04). The SII exhibited a correlation with elevated levels of C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), suggesting its potential as a marker of systemic inflammation. Nevertheless, the observed correlation between SII and ESSDAI scores (r = 0.0903) was weak and not statistically significant (p = 0.524). Although SII values were higher in SS patients and correlated with systemic inflammation markers, no statistically significant relationship was observed between these values and disease activity, as measured by ESSDAI.Thus, while SII may reflect systemic inflammation, its utility as a marker for disease activity in SS remains limited. Further studies are needed to elucidate its role in clinical settings.
- Open Access
- 31 December 2024
- Published by Turkish Journal of Clinics and Laboratory in TURKISH JOURNAL of CLINICS and LABORATORY
- Vol. 15 (4) , 547-553
Evaluation Of Compression Garment Compliance Factors İn Breast Cancer Patients
Aim: Complete decongestive therapy (CDT) is the standard treatment of postmastectomy lymphedema. Our study aimed to determine the factors that impair compliance with the compression garment, one of the main phases of CDT, and to reduce the limiting effects of lymphedema by increasing the treatment compliance of lymphedema patients. Material and Methods: In this prospective study, demographic and clinical information of the patients were recorded. The stage of lymphedema (International Society of Lymphology (ISL)) and whether they had received lymphedema treatment before were questioned. The experience of pressure garment use was evaluated with a 5-point Likert-type scale questionnaire covering factors affecting patient compliance. Results: The mean age of 71 postmastectomy lymphedema patients was 56.3±8.6 years. 29 patients (40.8%) used their compression garments regularly every day, while 42 (59.1%) patients did not use them regularly. Regarding the mean score values, the top 3 reasons for limiting factors impairing compliance with the pressure garment were as follows: the patients had the most problems putting on and taking off the garment (3.94±1.30), had difficulty in housework in daily life (3.92±1.36), and had difficulty in participating in sports and hobby activities (3.84±1.41). Conclusion: Patients' specific characteristics, lifestyle, and history are important in the selection of compression garments. It is important to identify factors that impair compliance with the compression garment, to inform patients about lymphedema preventive measures, and to enable them to better adapt to daily life with the compression garment may improve self-treatment management and reduce the need for caregivers
- 31 December 2024
- Published by Turkish Journal of Clinics and Laboratory in TURKISH JOURNAL of CLINICS and LABORATORY
- Vol. 15 (4) , 547-553
Open AccessEvaluation Of Compression Garment Compliance Factors İn Breast Cancer Patients
Aim: Complete decongestive therapy (CDT) is the standard treatment of postmastectomy lymphedema. Our study aimed to determine the factors that impair compliance with the compression garment, one of the main phases of CDT, and to reduce the limiting effects of lymphedema by increasing the treatment compliance of lymphedema patients. Material and Methods: In this prospective study, demographic and clinical information of the patients were recorded. The stage of lymphedema (International Society of Lymphology (ISL)) and whether they had received lymphedema treatment before were questioned. The experience of pressure garment use was evaluated with a 5-point Likert-type scale questionnaire covering factors affecting patient compliance. Results: The mean age of 71 postmastectomy lymphedema patients was 56.3±8.6 years. 29 patients (40.8%) used their compression garments regularly every day, while 42 (59.1%) patients did not use them regularly. Regarding the mean score values, the top 3 reasons for limiting factors impairing compliance with the pressure garment were as follows: the patients had the most problems putting on and taking off the garment (3.94±1.30), had difficulty in housework in daily life (3.92±1.36), and had difficulty in participating in sports and hobby activities (3.84±1.41). Conclusion: Patients' specific characteristics, lifestyle, and history are important in the selection of compression garments. It is important to identify factors that impair compliance with the compression garment, to inform patients about lymphedema preventive measures, and to enable them to better adapt to daily life with the compression garment may improve self-treatment management and reduce the need for caregivers
- Open Access
- 31 October 2024
- Published by MediHealth Academy in Journal of Orthopedics Research and Rehabilitation
- Vol. 2 (4) , 79-81
Atypical Milroy's disease with predominant unilateral involvement: a case report
Milroy's disease (MD), known as hereditary lymphedema type I, is a rare autosomal dominant primary lymphedema. It accounts for about twenty percent of all primary lymphedema. MD typically presents clinically with bilateral lower extremity lymphedema. Our case report describes a rare case of MD presenting with unilateral upper and lower extremity lymphedema in a patient admitted to our clinic. A 24-year-old woman who had been followed for lymphedema since the age of 8 was diagnosed with MD at our hospital by physical examination, venous Doppler ultrasound, whole-body lymphoscintigraphy, and molecular genetic testing. Partial improvement was observed with complete decongestive therapy, considered the gold standard treatment for lymphedema. Genetic counseling may be beneficial for the patient and family. Although MD is uncommon in the literature, many more studies are needed to identify carrier variants in the community.
- 31 October 2024
- Published by MediHealth Academy in Journal of Orthopedics Research and Rehabilitation
- Vol. 2 (4) , 79-81
Open AccessAtypical Milroy's disease with predominant unilateral involvement: a case report
Milroy's disease (MD), known as hereditary lymphedema type I, is a rare autosomal dominant primary lymphedema. It accounts for about twenty percent of all primary lymphedema. MD typically presents clinically with bilateral lower extremity lymphedema. Our case report describes a rare case of MD presenting with unilateral upper and lower extremity lymphedema in a patient admitted to our clinic. A 24-year-old woman who had been followed for lymphedema since the age of 8 was diagnosed with MD at our hospital by physical examination, venous Doppler ultrasound, whole-body lymphoscintigraphy, and molecular genetic testing. Partial improvement was observed with complete decongestive therapy, considered the gold standard treatment for lymphedema. Genetic counseling may be beneficial for the patient and family. Although MD is uncommon in the literature, many more studies are needed to identify carrier variants in the community.
- Open Access
- 27 October 2024
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 7 (6) , 626-631
Exploring the causes of kinesiophobia in patients with breast cancer-related lymphedema: a comprehensive study
Aims: Breast cancer is the most common cancer in women worldwide. Breast cancer survivors often experience arm and shoulder pain, limited shoulder range of motion, and lymphedema as the most common post-treatment morbidities. All these morbidities can be considered as the main causes of the fear of movement, called kinesiophobia. This is the first study aims to evaluate the biological and psychological causes of kinesiophobia in breast cancer-related lymphedema (BCRL), the relationship between kinesiophobia and BCRL, and the impact of kinesiophobia on patients’ upper extremity function and quality of life. The biological and psychological causes of kinesiophobia in women with breast cancer-related lymphoedema were investigated for the first time in the literature. Methods: Patients with BCRL were included in the study. Demographic and clinical information including age, educational status, body-mass index (BMI), and dominant upper extremity were recorded. BCRL stage (International Society of Lymphology (ISL) Scale), Quality of Life Scale [European Organisation for Research and Treatment of Cancer Quality of Life (EORTC QLO-C30)], upper extremity functional status [Quick-Disabilities of the Arm, Shoulder and Hand Score (Quick-DASH)], Tampa Kinesiophobia Scale (TKS), Kinesiophobia Causes Scale (KCS) were assessed. Results: The mean age of the 114 patients included in the study was 58.25±9.41 years. A total of 100 patients exhibited a TKS score above 37, indicative of kinesiophobia. There was a statistically significant positive correlation between age and BMI and total TKS score (p
- 27 October 2024
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 7 (6) , 626-631
Open AccessExploring the causes of kinesiophobia in patients with breast cancer-related lymphedema: a comprehensive study
Aims: Breast cancer is the most common cancer in women worldwide. Breast cancer survivors often experience arm and shoulder pain, limited shoulder range of motion, and lymphedema as the most common post-treatment morbidities. All these morbidities can be considered as the main causes of the fear of movement, called kinesiophobia. This is the first study aims to evaluate the biological and psychological causes of kinesiophobia in breast cancer-related lymphedema (BCRL), the relationship between kinesiophobia and BCRL, and the impact of kinesiophobia on patients’ upper extremity function and quality of life. The biological and psychological causes of kinesiophobia in women with breast cancer-related lymphoedema were investigated for the first time in the literature. Methods: Patients with BCRL were included in the study. Demographic and clinical information including age, educational status, body-mass index (BMI), and dominant upper extremity were recorded. BCRL stage (International Society of Lymphology (ISL) Scale), Quality of Life Scale [European Organisation for Research and Treatment of Cancer Quality of Life (EORTC QLO-C30)], upper extremity functional status [Quick-Disabilities of the Arm, Shoulder and Hand Score (Quick-DASH)], Tampa Kinesiophobia Scale (TKS), Kinesiophobia Causes Scale (KCS) were assessed. Results: The mean age of the 114 patients included in the study was 58.25±9.41 years. A total of 100 patients exhibited a TKS score above 37, indicative of kinesiophobia. There was a statistically significant positive correlation between age and BMI and total TKS score (p
- Open Access
- 26 October 2024
- Published by Journal of Medicine and Palliative Care in Journal of Medicine and Palliative Care
- Vol. 5 (5) , 226-230
Functional balance and quality of life in breast cancer survivors
Aims: Breast cancer is an important health problem with the second mortality rate in cancer-related deaths in women. After mastectomy and radiotherapy, shoulder and upper extremity mobility may decrease, trunk and upper extremity muscles may weaken, and biomechanical and functional balance may be impaired in women who have survived breast cancer. In addition, increased limb volume due to breast cancer-related lymphedema (BCRL) may impair static and dynamic balance. To date, studies investigating the effect of lymphedema on balance in BCRL are limited. We aimed to examine the impact of lymphedema on balance and quality of life in breast cancer survivors. Methods: In this prospective study, age, education, marital status, body mass index (BMI) (kg/m2), affected lymphedema limb (right-left), and extremity volume difference were evaluated. Fullerton Advanced Balance Scale (FAB-Scale) was applied to the patients to measure their level of balance. The Lymphedema Quality of Life Questionnaire (LYMQOL-Arm) was applied. Results: The mean age of the 40 patients included in the study was 59.02±7.50 years. The proportion of patients with a Fab-scale ≤25 who were at risk of falls was 55%. There was no statistical difference between patients with Fab-scale ≤25 and patients with Fab-scale 250.05). Conclusion: In our study, balance deteriorated and the risk of falls increased especially in elderly patients. Every woman with BCRL should be informed about balance and gait impairment and encouraged to receive lymphoedema treatment as soon as possible. We think that future studies examining functional stability, quality of life, and fall risk in the treatment of lymphedema and the development of special interventions related to balance will contribute to the oncological rehabilitation protocol.
- 26 October 2024
- Published by Journal of Medicine and Palliative Care in Journal of Medicine and Palliative Care
- Vol. 5 (5) , 226-230
Open AccessFunctional balance and quality of life in breast cancer survivors
Aims: Breast cancer is an important health problem with the second mortality rate in cancer-related deaths in women. After mastectomy and radiotherapy, shoulder and upper extremity mobility may decrease, trunk and upper extremity muscles may weaken, and biomechanical and functional balance may be impaired in women who have survived breast cancer. In addition, increased limb volume due to breast cancer-related lymphedema (BCRL) may impair static and dynamic balance. To date, studies investigating the effect of lymphedema on balance in BCRL are limited. We aimed to examine the impact of lymphedema on balance and quality of life in breast cancer survivors. Methods: In this prospective study, age, education, marital status, body mass index (BMI) (kg/m2), affected lymphedema limb (right-left), and extremity volume difference were evaluated. Fullerton Advanced Balance Scale (FAB-Scale) was applied to the patients to measure their level of balance. The Lymphedema Quality of Life Questionnaire (LYMQOL-Arm) was applied. Results: The mean age of the 40 patients included in the study was 59.02±7.50 years. The proportion of patients with a Fab-scale ≤25 who were at risk of falls was 55%. There was no statistical difference between patients with Fab-scale ≤25 and patients with Fab-scale 250.05). Conclusion: In our study, balance deteriorated and the risk of falls increased especially in elderly patients. Every woman with BCRL should be informed about balance and gait impairment and encouraged to receive lymphoedema treatment as soon as possible. We think that future studies examining functional stability, quality of life, and fall risk in the treatment of lymphedema and the development of special interventions related to balance will contribute to the oncological rehabilitation protocol.
- Open Access
Dropped head syndrome secondary to head and neck cancer: Impact on functıonal and body image scale